SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 244 filers reported holding SELECT MED HLDGS CORP in Q4 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $306,146 | -2.2% | 12,115 | +23.4% | 0.04% | +2.6% |
Q2 2023 | $312,897 | +14.2% | 9,821 | -7.4% | 0.04% | +8.6% |
Q1 2023 | $274,062 | +11.2% | 10,602 | +6.9% | 0.04% | +9.4% |
Q4 2022 | $246,360 | +20.2% | 9,922 | +6.8% | 0.03% | +10.3% |
Q3 2022 | $205,000 | -3.8% | 9,291 | +3.2% | 0.03% | +3.6% |
Q2 2022 | $213,000 | -10.5% | 9,005 | -9.2% | 0.03% | 0.0% |
Q1 2022 | $238,000 | -4.0% | 9,920 | +17.4% | 0.03% | 0.0% |
Q4 2021 | $248,000 | +3.8% | 8,449 | +28.0% | 0.03% | -6.7% |
Q3 2021 | $239,000 | -77.2% | 6,600 | -73.4% | 0.03% | -78.3% |
Q2 2021 | $1,050,000 | +250.0% | 24,840 | +22.1% | 0.14% | +32.7% |
Q2 2020 | $300,000 | +20.5% | 20,336 | +22.4% | 0.10% | +5.1% |
Q1 2020 | $249,000 | +34.6% | 16,621 | +49.1% | 0.10% | +39.4% |
Q3 2019 | $185,000 | +8.2% | 11,147 | +3.6% | 0.07% | -1.4% |
Q2 2019 | $171,000 | +11.8% | 10,761 | -0.9% | 0.07% | +1.4% |
Q1 2019 | $153,000 | +155.0% | 10,860 | +217.7% | 0.07% | +39.2% |
Q4 2017 | $60,000 | – | 3,418 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hillcrest Asset Management LLC | 455,999 | $13,406,000 | 2.04% |
Smith, Graham & Co., Investment Advisors, LP | 445,634 | $13,102,000 | 1.30% |
DENALI ADVISORS LLC | 118,200 | $3,475,000 | 1.30% |
Huber Capital Management LLC | 155,484 | $4,571,000 | 1.20% |
Sivik Global Healthcare LLC | 90,000 | $2,646,000 | 1.13% |
Hood River Capital Management LLC | 1,163,403 | $34,204,000 | 1.02% |
Phocas Financial Corp. | 234,059 | $6,881,000 | 0.88% |
BOULDER HILL CAPITAL MANAGEMENT LP | 18,600 | $547,000 | 0.53% |
Orbimed Advisors | 1,233,600 | $36,268,000 | 0.47% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,385,402 | $70,131,000 | 0.41% |